Table 3.
Top diseases and biological functions associated with the dataset in IPA
| Top diseases and biofunctions | ||
|---|---|---|
| Name | P-value rangea | Number of molecules |
| Diseases and disorders | ||
| Inflammatory response | 2.89E−03 to 5.29E−10 | 222 |
| Immunological disease | 2.89E−03 to 1.65E−06 | 134 |
| Gastrointestinal disease | 2.89E−03 to 2.32E−06 | 148 |
| Organismal injury and abnormalities | 2.94E−03 to 3.19E−06 | 291 |
| Cancer | 2.94E−0.3 to 4.28E−06 | 177 |
| Molecular and cellular functions | ||
| Cell death and survival | 2.51E−03 to 1.64E−10 | 274 |
| Cellular compromise | 2.80E−03 to 1.64E−10 | 75 |
| Cell-to-cell signalling and interaction | 2.91E−03 to 1.41E−07 | 197 |
| Cellular movement | 2.62E−03 to 4.10E−07 | 190 |
| Cellular function and maintenance | 2.81E−03 to 7.99E−07 | 141 |
| Physiological system development and function | ||
| Hematological system development and function | 2.91E−03 to 7.82E−10 | 185 |
| Tissue morphology | 2.81E−03 to 7.82E−10 | 161 |
| Lymphoid tissue structure and development | 2.51E−03 to 1.97E−07 | 125 |
| Immune cell trafficking | 2.62E−03 to 4.75E−06 | 115 |
| Digestive system Development and function | 2.40E−03 to 6.27E−06 | 44 |
aThe P-value indicates significance with which the attributes were associated with the dataset and the number of molecules indicates the number of genes from the dataset that were associated with it